GYRUS ACMI, INC.
Manufacturer adverse-event records for GYRUS ACMI, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2004–2026 · thin-book · typical Death-code · balanced
Volume signature
GYRUS ACMI, INC. is a thinner MAUDE footprint
GYRUS ACMI, INC. accounts for 4,706 FDA MAUDE reports (#374 of 443, thin-book tercile). Death-coded event_type share is 0.34% (typical); Injury share 16.8% (balanced).
What the volume reading shows for GYRUS ACMI, INC.
The standout signal for GYRUS ACMI, INC. is filing volume: 4,706 adverse-event reports in FDA MAUDE (#374 of 443, thin-book). Death-coded event_type share sits at 0.34% (typical).
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 20 device types, led in this extract by Malfunction at 3,811 (81.0% of event_type total). Peak single-year volume reaches 1,658 reports across 21 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.